PRESS RELEASE published on 02/04/2026 at 18:00, 6 months 5 days ago Lithium South AGSM Update Lithium South provides update on annual and special meeting of securityholders, including details on the sale of subsidiary and going private arrangement. Shareholders to vote on USD$65,000,000 sale. Company aims to maximize shareholder value through the negotiated transaction with POSCO Securityholders Sale Of Subsidiary Lithium South POSCO Going Private Arrangement
BRIEF published on 12/08/2025 at 18:55, 8 months 1 day ago Lithium South Development Corp. signe un accord avec POSCO Argentina Lithium Sud Accord POSCO Actions De Rachat Radiation De La Cote De La Bourse De Toronto (TSXV) Vente De Métaux NRG
BRIEF published on 12/08/2025 at 18:55, 8 months 1 day ago Lithium South Development Corp. Signs Agreement with POSCO Argentina Share Redemption TSXV Delisting Lithium South POSCO Agreement NRG Metals Sale
PRESS RELEASE published on 12/08/2025 at 18:50, 8 months 1 day ago Lithium South Announces Signing of Acceptance Letter for Share Purchase Agreement with POSCO Argentina S.A.U. Lithium South announces sale of NRG Metals Argentina S.A. for US$65 million to POSCO. Shareholders to vote on transaction at AGSM on Feb 19, 2026 Share Sale AGSM Lithium South NRG Metals POSCO
BRIEF published on 11/20/2025 at 18:45, 8 months 19 days ago Lithium South prolonge son accord d'achat d'actions avec POSCO Argentina Lithium Sud Extension SPA POSCO Argentine Homme Mort Métaux NRG
BRIEF published on 11/20/2025 at 18:45, 8 months 19 days ago Lithium South Extends Share Purchase Agreement with POSCO Argentina Lithium South POSCO Argentina SPA Extension Hombre Muerto NRG Metals
PRESS RELEASE published on 11/20/2025 at 18:40, 8 months 19 days ago Lithium South Announces Extension to POSCO Argentina S.A.U. Share Purchase Agreement Lithium South Development Corporation extends Share Purchase Agreement deadline with POSCO Argentina S.A.U. for US$65 million sale of NRG Metals Argentina S.A. subsidiary Share Purchase Agreement Hombre Muerto North Lithium Project Lithium South Development Corporation POSCO Argentina S.A.U. NRG Metals Argentina S.A.
BRIEF published on 11/12/2025 at 17:25, 8 months 27 days ago Lithium South Development Secures Approval for POSCO Acquisition Shareholder Meeting Lithium Acquisition POSCO Approval HMN Project TSX Exchange
BRIEF published on 11/12/2025 at 17:25, 8 months 27 days ago Lithium South Development obtient l'approbation pour l'acquisition de POSCO Assemblée Générale Des Actionnaires Acquisition De Lithium Approbation POSCO Projet HMN Bourse De Toronto (TSX)
PRESS RELEASE published on 11/12/2025 at 17:20, 8 months 27 days ago Lithium South Gets Green Light from POSCO Lithium South announces approval of acquisition by POSCO Argentina for Hombre Muerto North Lithium Project. Final acquisition price set at US$65 million Acquisition Investment Lithium South POSCO Argentina Hombre Muerto North Lithium Project
Published on 08/10/2026 at 08:00, 1 hour 57 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 1 hour 57 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 10 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:00, 56 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 57 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 34 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 34 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 2 hours 57 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 2 hours 57 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
